Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression

Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression

The human epidermal growth factor receptor 2 (Her2) is tested in many human cancers, including breast, bladder, pancreatic, ovarian and stomach. The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) have issued Clinical Practice Guidelines for reporting Her2 results...

Full description

Bibliographic Details
Main Authors: M. Ruhul Quddus, Katrine Hansen, Umadevi Tantravahi, C. James Sung
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Gynecologic Oncology Reports
Subjects:
Her2/neu
Endometrial carcinoma
Papillary serous carcinoma
FISH amplification
Her2/neu testing
Fixation and cold ischemia time
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578920300278

Internet

http://www.sciencedirect.com/science/article/pii/S2352578920300278

Similar Items